Trafalgar International (GCAN) Current Assets (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Current Assets of $1439.0 for Q1 2026, down 96.89% year-over-year from $46213.0 in Q1 2025, and up 76.56% quarter-over-quarter from $815.0 in Q4 2025.
Trafalgar International (GCAN) Current Assets (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Current Assets history runs 10 years deep, the most recent figure standing at $1439.0 for Q1 2026.
- In Q1 2026, Current Assets fell 96.89% year-over-year to $1439.0; the TTM figure through Mar 2026 stood at $1439.0 (down 96.89% YoY), while the FY2025 annual figure was $815.0, down 98.58% from the prior year.
- Current Assets for Q1 2026 stood at $1439.0, up from $815.0 in the prior quarter.
- The five-year high for Current Assets was $367589.0 in Q1 2022, with the low at $815.0 in Q4 2025.
- The 5-year median for Current Assets is $129323.0 (2024), against an average of $148377.9.
- The sharpest annual moves came in 2022 and 2025: Current Assets increased 3.99% in 2022, then slumped 98.58% in 2025.
- Greater Cannabis Company's Current Assets stood at $270030.0 in 2022, then tumbled by 38.21% to $166859.0 in 2023, then slumped by 65.62% to $57368.0 in 2024, then plunged by 98.58% to $815.0 in 2025, then jumped by 76.56% to $1439.0 in 2026.
- Business Quant data shows GCAN's Current Assets at $1439.0 in Q1 2026, $815.0 in Q4 2025, and $21355.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 1,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,439.00 |
| Dec 31, 2025 | 815.00 |
| Sep 30, 2025 | 21,355.00 |
| Jun 30, 2025 | 26,712.00 |
| Mar 31, 2025 | 46,213.00 |
| Dec 31, 2024 | 57,368.00 |
| Sep 30, 2024 | 62,282.00 |
| Jun 30, 2024 | 80,316.00 |
| Mar 31, 2024 | 129,323.00 |
| Dec 31, 2023 | 166,859.00 |
| Sep 30, 2023 | 199,532.00 |
| Jun 30, 2023 | 240,747.00 |
| Mar 31, 2023 | 251,553.00 |
| Dec 31, 2022 | 270,030.00 |
| Sep 30, 2022 | 289,094.00 |
| Jun 30, 2022 | 311,197.00 |
| Mar 31, 2022 | 367,589.00 |
| Dec 31, 2021 | 377,520.00 |
| Sep 30, 2021 | 493,108.00 |
| Jun 30, 2021 | 565,680.00 |